We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · August 08, 2022

Effect of 4% Albumin Solution vs Ringer Acetate on Major Adverse Events in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass

JAMA: The Journal of the American Medical Association

 

Additional Info

JAMA: The Journal of the American Medical Association
Effect of 4% Albumin Solution vs Ringer Acetate on Major Adverse Events in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass: A Randomized Clinical Trial
JAMA 2022 Jul 19;328(3)251-258, E Pesonen, H Vlasov, R Suojaranta, S Hiippala, A Schramko, E Wilkman, T Eränen, K Arvonen, M Mazanikov, US Salminen, M Meinberg, T Vähäsilta, L Petäjä, P Raivio, T Juvonen, V Pettilä

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading